Matches in Wikidata for { <http://www.wikidata.org/entity/Q90068791> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q90068791 description "article scientifique publié en 2017" @default.
- Q90068791 description "artículu científicu espublizáu en xunu de 2017" @default.
- Q90068791 description "scientific article published on 01 June 2017" @default.
- Q90068791 description "wetenschappelijk artikel" @default.
- Q90068791 description "наукова стаття, опублікована в червні 2017" @default.
- Q90068791 name "KEYNOTE-059 cohort 3: safety and efficacy of pembrolizumab monotherapy for first-line treatment of patients (pts) with PD-L1-positive advanced gastric/gastroesophageal (G/GEJ) cancer" @default.
- Q90068791 name "KEYNOTE-059 cohort 3: safety and efficacy of pembrolizumab monotherapy for first-line treatment of patients (pts) with PD-L1-positive advanced gastric/gastroesophageal (G/GEJ) cancer" @default.
- Q90068791 type Item @default.
- Q90068791 label "KEYNOTE-059 cohort 3: safety and efficacy of pembrolizumab monotherapy for first-line treatment of patients (pts) with PD-L1-positive advanced gastric/gastroesophageal (G/GEJ) cancer" @default.
- Q90068791 label "KEYNOTE-059 cohort 3: safety and efficacy of pembrolizumab monotherapy for first-line treatment of patients (pts) with PD-L1-positive advanced gastric/gastroesophageal (G/GEJ) cancer" @default.
- Q90068791 prefLabel "KEYNOTE-059 cohort 3: safety and efficacy of pembrolizumab monotherapy for first-line treatment of patients (pts) with PD-L1-positive advanced gastric/gastroesophageal (G/GEJ) cancer" @default.
- Q90068791 prefLabel "KEYNOTE-059 cohort 3: safety and efficacy of pembrolizumab monotherapy for first-line treatment of patients (pts) with PD-L1-positive advanced gastric/gastroesophageal (G/GEJ) cancer" @default.
- Q90068791 P1433 Q90068791-9FCE0FC7-F710-4A65-A29A-AC273ECEC659 @default.
- Q90068791 P1476 Q90068791-6D203858-239B-4487-8F7C-0FCC6140E22B @default.
- Q90068791 P2093 Q90068791-11EA0AC3-7D2B-4EB2-8FE5-F2B0F9EF4BD9 @default.
- Q90068791 P2093 Q90068791-12C388A1-9646-47A6-8EBB-0336AA1FB71A @default.
- Q90068791 P2093 Q90068791-47A46C07-DC3F-423B-B233-1D4C46C629D7 @default.
- Q90068791 P2093 Q90068791-5DDCA91D-1008-4D3D-9AC2-CB1A7C0C5D45 @default.
- Q90068791 P2093 Q90068791-7ADD31ED-3CD6-4314-9287-C2100827C9AD @default.
- Q90068791 P2093 Q90068791-8271C921-AAF2-4278-8D71-B8B7D5928DED @default.
- Q90068791 P2093 Q90068791-87182B05-FC1C-416F-972C-1C97C9279B0A @default.
- Q90068791 P2093 Q90068791-CDDF0CEF-2CE3-451E-AB56-B43FFE07777E @default.
- Q90068791 P2093 Q90068791-D4EEC160-F866-4A63-9992-2E48987BE0D5 @default.
- Q90068791 P2093 Q90068791-DFF3396B-2827-4995-81EF-266AE9359D84 @default.
- Q90068791 P304 Q90068791-A612161F-1AEF-4659-8F70-76420186991D @default.
- Q90068791 P31 Q90068791-8518C3B8-5CA5-4EC0-A3B5-52C0EEFCFC3D @default.
- Q90068791 P356 Q90068791-8B08D641-2A90-4820-A702-2527E8612904 @default.
- Q90068791 P478 Q90068791-C37AC0DE-23B1-4AB6-8186-B20855F4161D @default.
- Q90068791 P50 Q90068791-D13CE90D-4A41-4153-BD97-4311257F6DA9 @default.
- Q90068791 P577 Q90068791-66FD0F0C-BEBA-4785-8D9A-B46081BCC1CC @default.
- Q90068791 P921 Q90068791-82E76B58-EF18-4FDA-9325-860CFE4B5690 @default.
- Q90068791 P356 MDX302.008 @default.
- Q90068791 P1433 Q326122 @default.
- Q90068791 P1476 "KEYNOTE-059 cohort 3: safety and efficacy of pembrolizumab monotherapy for first-line treatment of patients (pts) with PD-L1-positive advanced gastric/gastroesophageal (G/GEJ) cancer" @default.
- Q90068791 P2093 "Jiangdian Wang" @default.
- Q90068791 P2093 "Kei Muro" @default.
- Q90068791 P2093 "Marcelo Garrido" @default.
- Q90068791 P2093 "Mary Savage" @default.
- Q90068791 P2093 "Minori Koshiji" @default.
- Q90068791 P2093 "P Dalal Rita" @default.
- Q90068791 P2093 "S Fuchs Charles" @default.
- Q90068791 P2093 "V Catenacci Daniel" @default.
- Q90068791 P2093 "Yoon-Koo Kang" @default.
- Q90068791 P2093 "Zev Wainberg" @default.
- Q90068791 P304 "iii153" @default.
- Q90068791 P31 Q13442814 @default.
- Q90068791 P356 "10.1093/ANNONC/MDX302.008" @default.
- Q90068791 P478 "28 Suppl 3" @default.
- Q90068791 P50 Q16180903 @default.
- Q90068791 P577 "2017-06-01T00:00:00Z" @default.
- Q90068791 P921 Q13896859 @default.